CRYO-CELL INTERNATIONAL, INC. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent of 0.08% for the 12-month period ending 2025-11-30, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-02-27
- CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2025 was 0.08%.
- CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2024 was -0.43%.
- CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2023 was -0.04%.
- CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2022 was -0.27%, a 135.06% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 12 month |
|---|---|
| 2025-11-30 | 0.08% 10-K · filed 2026-02-27 |
| 2024-11-30 | -0.43% 10-K · filed 2026-02-27 |
| 2023-11-30 | -0.04% 10-K · filed 2025-02-28 |
| 2022-11-30 | -0.27% 10-K · filed 2024-02-28 |
| 2021-11-30 | 0.77% 10-K · filed 2023-02-28 |
| 2020-11-30 | -2.92% 10-K · filed 2022-02-22 |
| 2019-11-30 | 0.35% 10-K · filed 2021-03-01 |
| 2016-11-30 | 0.00% 10-K · filed 2017-02-28 |
| 2015-11-30 | 33.00% 10-K · filed 2017-02-28 |
| 2014-11-30 | -37.70% 10-K · filed 2016-02-29 |
| 2013-11-30 | -58.40% 10-K · filed 2015-03-02 |
| 2012-11-30 | 69.50% 10-K · filed 2014-02-28 |
| 2011-11-30 | 37.40% 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |